Neutrophils from Patients with Myelodysplastic Syndromes: Relationship between Impairment of Granular Contents, Complement Receptors, Functional Activities and Disease Status

References

• Bennet J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Granlick H. R., Sultan C., The French-American-British (FAB) cooperative group. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Bennet J. M., Catovsky D., Daniel M., Flandrin G., Galton D., Granlick H., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann. Intern. Med. 1985; 103: 626–629
   PubMedGoogle Scholar
• Third M IC, Cooperative Study Group, Bennet J. M., Sandberg A. A. Recommendations for a Morphologic, Immunologic and Cytogenetic (MIC) Working classification of the primary and therapy-related myelodysplastic disorders. Cancer Genet. Cylogenet. 1988; 32: 1–10
   PubMed Web of Science ®Google Scholar
• Jacobs A. Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J. Clin. Pathol. 1985; 38: 1201–1217
   PubMed Web of Science ®Google Scholar
• Tricot G. J. Prognostic factors in the myelodysplastic syndromes. Leuk. Res. 1992; 16: 109–115
   PubMed Web of Science ®Google Scholar
• Jacobs A. Human preleukaemia: Do we have a model?. Br. J. Cancer 1987; 55: 1–5
   PubMed Web of Science ®Google Scholar
• Galton D. A. G. The myelodysplastic syndromes. Clin. Lab. Haematol. 1984; 6: 99–112
   PubMedGoogle Scholar
• Goasguen J., Garand R., Bizet M., Bremond J., Gardais J., Callat M., Accard F., Chaperon J. Prognostic factors of myelodysplastic syndromes- a simplified 3-D scoring system. Leuk. Res. 1990; 14: 255–262
   PubMed Web of Science ®Google Scholar
• May S. J., Smith S. A., Jacobs A., Williams A., Bailey-Wood R. The myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classification. Br. J. Haematol. 1985; 59: 311–319
   PubMed Web of Science ®Google Scholar
• Lanza F. Displasie Emopoietiche. Tumori e pre-cancerosi, G. Lanza. Piccin Publisher, Padova 1989; 360–374
   Google Scholar
• Mufti G. J., Stevens J. R., Oscier D. G., Hamblin T. J., Machin D. Myelodysplastic syndromes: a scoring system with prognostic significance. Br. J. Haematol. 1985; 59: 425–433
   PubMed Web of Science ®Google Scholar
• Van der Weide M., Sizoo W., Krefft J., Langenhuijsen M. Myelodysplastic syndromes: analysis of morphological features related to the FAB-classification. Eur. J. Haematol. 1988; 41: 58–61
   PubMed Web of Science ®Google Scholar
• Cazzola M., Riccardi A. Myelodysplastic syndromes: biologic and clinical aspects. Haematologica 1986; 71: 147–159
   PubMedGoogle Scholar
• Delacretaz F., Schmidt P. M., Piguet D., Bachmann F., Costa J. Histopathology of myelodysplastic syndromes. Am. J. Clin. Pathol. 1987; 87: 180–187
   PubMed Web of Science ®Google Scholar
• Zwierzina H., Mufti G. J., Schmalzl F. Therapy of myelodysplastic syndromes: advances and perspectives. Leukemia 1990; 5: 166–185
   Web of Science ®Google Scholar
• Heim S. Cytogenetic findings in primary and secondary MDS. Leuk. Res. 1992; 16: 43–46
   PubMed Web of Science ®Google Scholar
• Yunis J. J., Rydell R. E., Oken M. M., Arnesen M. A., Mayer M. G., Lobell M. Refined chromosome analysis as independent prognostic indicator in de novo myelodysplastic syndromes. Blood 1986; 67: 1721–1730
   PubMed Web of Science ®Google Scholar
• Jacobs R. H., Cornbleet M. H., Vardiman J. W., Larson R. A., Le Beau M. M., Rowley J. D. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 1986; 67: 1765–1772
   PubMed Web of Science ®Google Scholar
• Iwabuchi A., Ohyashiki K., Ohyashiki J. H., Sasao I., Murakami T., Kodama A., Toyama K. Trysomy of chromosome 8 in myelodysplastic syndrome. Cancer Genet. Cytogenet. 1992; 62: 70–74
   PubMed Web of Science ®Google Scholar
• Brito-Babapulle F., Catovsky D., Galton D. A. G. Clinical and laboratory features of de novo acute myeloid leukemia with trilineage myelodysplasia. Br. J. Haematol. 1987; 66: 445–454
   PubMed Web of Science ®Google Scholar
• Goasguen J. E., Matsuo T., Cox C., Bennet M. Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: major importance of dysgranulo-poiesis for remission and survival. Leukemia 1992; 6: 520–525
   PubMed Web of Science ®Google Scholar
• Mason D. Y. Intracellular lysozyme and lactoferrin in myeloproliferative disorders. J. Clin. Pathol. 1977; 30: 541–546
   PubMed Web of Science ®Google Scholar
• Davey F. R., Erber W. N., Gatter K. C., Mason D. Y. Abnormal neutrophils in acute myeloid leukemia and myelodysplastic syndrome. Human Pathol. 1988; 19: 454–459
   PubMed Web of Science ®Google Scholar
• Mazzone A., Ricevuti G., Pasotti D., Fossati G., Maz-Zuchelli I, Cavigliano P., Notario A. The CD11/ CD 18 granulocyte adhesion molecules in myelodisplastic syndromes. Br. J. Hematol. 1992; 83: 245–252
   Web of Science ®Google Scholar
• Traniello S., Spisani S., Gavioli R., Dovigo L., Bari-Cordi O R, Sensi A., Damiani G. Deficiency of neutrophil membrane antigen detected by monoclonal antibody in rheumatoid arthritis. FEBS Lett. 1986; 204: 47–49
   PubMed Web of Science ®Google Scholar
• Lanza F., Latorraca A., Musto P., Ferrari L., Moretti S., Zabucchi G., Carotenuto M., Castoldi G. L. Cy-tochemical unreactive neutrophils from subjects with myeloperoxidase deficiency (MPO) show a complex pattern of im-munoreactivity with anti-MPO monoclonal antibodies. Ann. Hematol. 1991; 62: 1–7
   Web of Science ®Google Scholar
• Wilkinson P. C. Outline method for measuring chem-otaxis. Chemotaxis and Inflammation, P. C. Wilkinson. Churchill Livingstone, Edinburgh 1974; 148–172
   Google Scholar
• Zigmond S. H., Hirsh J. G. Leukocyte locomotion and chemotaxis: new method for evaluation and demonstration of a derived chemotactic factor. J. Exp. Med. 1973; 137: 387–410
   PubMed Web of Science ®Google Scholar
• Nelson R. D., Herron N. S. Agarose method for human neutrophil chemotaxis. Methods of Enzymology, G. Di, Sabato. Academic Press, London 1988; vol. 162: 50–59
   Google Scholar
• Absolon D. R. Basic method for the study of phagocytosis. Methods of Enzymology, G. Di, Sabato. Academic Press, London 1986; 95–180
   Google Scholar
• Lanza F., Giuliani A. L., Amelotti F., Spisani S., Traniello S., Castoldi G. L. Depressed neutrophil-mediated tumor cell cytotoxicity in subjects affected by hereditary myeloperoxidase deficiency and secondary neoplasia. Haematologica 1988; 73: 355–358
   PubMed Web of Science ®Google Scholar
• Gavioli R., Spisani S., Giuliani A. L., Traniello S. Dual mechanism in induction of neutrophil cytotoxicity. Activation of protein kinase C and elevation in intracellular calcium. Clin. Exp. Immunol. 1990; 80: 247–251
   PubMed Web of Science ®Google Scholar
• Lanza F., Fagioli F., Gavioli R., Spisani S., Malavasi F., Castoldi G. L., Traniello S. Evaluation of CR1 expression in neutrophils from chronic myeloid leukemia: relationship between prognosis and cellular activity. Br. J. Haematol. 1991; 77: 66–72
   PubMed Web of Science ®Google Scholar
• Lanza F., Castoldi G. L. Complement receptor 1 (CR1) expression in chronic myeloid leukemia (review article). Leukemia and Lymphoma 1992; 8: 35–41
   PubMed Web of Science ®Google Scholar
• Hemler M. E. Adhesive protein receptors on hematopoietic cells. Immunol. Today 1988; 12: 109–113
   Google Scholar
• Lambris J. D. The multifunctional role of CR3, the third component of complement. Immunol. Today 1988; 12: 387–393
   Google Scholar
• Kinoshita T. The biology of the complement. Immunol. Today 1991; 12: 291–342
   PubMedGoogle Scholar
• Hansen K. B., Nielsen H. K. Myeloperoxidase-deficient polymorphonuclear leukocytes (IV): relation to FAB classification in acute myeloid leukemia. Scand. J. Haematol. 1985; 35: 174–177
   PubMedGoogle Scholar
• Boogaertz M. A., Nelissen V., Roelant C., Goosens W. Blood neutrophil function in primary myelodisplastic syndromes. Br. J. Haematol. 1983; 55: 217–224
   PubMed Web of Science ®Google Scholar
• Kuryama K., Tomonage M., Matsou T., Ginnai I., Ichimaru M. Diagnostic significance of detecting pseudo-Pelger-Huet anomalies and mycromegacaryocytes in myelodisplastic syndromes. Br. J. Haematol. 1986; 63: 665–673
   PubMed Web of Science ®Google Scholar
• Hast R., Nilsson I., Widell S., Ost A. Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromes. Leuk. Res. 1989; 13: 173–178
   PubMed Web of Science ®Google Scholar
• Hamblin T. Clinical features of MDS. Leuk. Res. 1992; 16: 89–93
   PubMed Web of Science ®Google Scholar